{
  "id": 13393739,
  "title": "Ongoing lawsuits allege GLP-1s can cause serious harm. But we don't know how often",
  "url": "https://urgent.news/2026/10/10/ongoing-lawsuits-allege-glp-1s-can-cause-serious-harm-but-we-dont",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-10T11:00:00.000Z",
  "source": {
    "name": "NPR Health",
    "slug": "npr-health",
    "url": "https://www.npr.org/2026/10/10/nx-s1-5996652/glp1-fda-naion-blind-lawsuit-ozempic"
  },
  "original_language": "en",
  "account": null,
  "summary": "Scant data about serious adverse effects makes it harder to answer scientific and legal questions about how often the drugs might cause serious harm like blindness or pancreatitis.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "NPR",
        "title": "Ongoing lawsuits allege GLP-1s can cause serious harm. But we don't know how often",
        "url": "https://urgent.news/2026/10/10/ongoing-lawsuits-allege-glp-1s-can-cause-serious-harm-but-we-dont-13395208",
        "published": "2026-10-10T11:00:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}